Founded by UK life sciences venture capital firm Medicxi, Centessa Pharmaceuticals is headed up by industry heavyweights. Saurabh Saha, who was formerly Bristol Myers Squibb Company’s head of R&D, has taken the helm as CEO, while GlaxoSmithKline plc veteran and the outgoing scientific head Operation Warp Speed, Moncef Slaoui, has been appointed chief scientific officer.
“There are significant improvements in R&D productivity that still need to happen, and that’s on improving success rates, timelines and...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?